Prognosis in the era of comparative effectiveness research: where is nuclear cardiology now and where should it be?
about
Women and Ischemic Heart Disease: Recognition, Diagnosis and ManagementComparative definitions for moderate-severe ischemia in stress nuclear, echocardiography, and magnetic resonance imagingEvaluation of inter-departmental variability of ejection fraction and cardiac volumes in myocardial perfusion scintigraphy using simulated dataDoes ischemia burden in stable coronary artery disease effectively identify revascularization candidates? Ischemia burden in stable coronary artery disease does not effectively identify revascularization candidates.The prognostic value of regadenoson myocardial perfusion imaging.Gender Differences in Radiation Dose From Nuclear Cardiology Studies Across the World: Findings From the INCAPS RegistryPrognosis of patients without perfusion defects with and without rest study in myocardial perfusion scintigraphy.Preserved coronary flow reserve effectively excludes high-risk coronary artery disease on angiographyUse of myocardial perfusion imaging and estimation of associated radiation doses in Germany from 2005 to 2012.Impact of Follow-Up Ischemia on Myocardial Perfusion Single-Photon Emission Computed Tomography in Patients with Coronary Artery Disease.Review of cardiovascular imaging in The Journal of Nuclear Cardiology in 2014: Part 2 of 2: Myocardial perfusion imaging.Stress cardiac magnetic resonance imaging provides effective cardiac risk reclassification in patients with known or suspected stable coronary artery disease.Clinical applications of radionuclide imaging in the evaluation and management of patients with congenital heart disease.Review of Cardiovascular Imaging in the Journal of Nuclear Cardiology in 2015-Part 2 of 2: Myocardial perfusion imaging.Myocardial perfusion imaging in women for the evaluation of stable ischemic heart disease-state-of-the-evidence and clinical recommendations.The prognostic value of non-perfusion variables obtained during vasodilator stress myocardial perfusion imaging.The reproducibility and prognostic value of serial measurements of heart rate response to regadenoson during myocardial perfusion imaging.Negative predictive value of stress myocardial perfusion imaging and coronary computed tomography angiography: A meta-analysis.Multi-modality imaging: Bird's eye view from the 2016 American Heart Association Scientific Sessions.Review of cardiovascular imaging in the journal of nuclear cardiology in 2016: Part 2 of 2-myocardial perfusion imaging.Crown years for non-invasive cardiovascular imaging (Part II): 40 years of nuclear cardiology.Effect of changes in perfusion defect size during serial regadenoson myocardial perfusion imaging on cardiovascular outcomes in high-risk patients.Single-photon emission computed tomography myocardial perfusion imaging-assessed stress perfusion defect severity is associated with mortality independent of ethnicity in an Asian population.Demonstration of Ischemia in Myocardial Perfusion Scintigraphy before Coronary Revascularization Decreases Acute Coronary Syndrome-related Hospitalizations.Stress-first single photon emission computed myocardial perfusion imaging.Stable ischemic heart disease in women: current perspectives.Anatomy vs physiology: is that the question?Comparison of three commercially available softwares for measuring left ventricular perfusion and function by gated SPECT myocardial perfusion imaging.Prognosis in patients with suspected or known ischemic heart disease and normal myocardial perfusion: long-term outcome and temporal risk variations.Prognosis in the era of comparative effectiveness research.Interpreting myocardial perfusion scintigraphy using single-photon emission computed tomography. Part 1.Serial imaging and outcome prediction.Medical therapy for the treatment of myocardial ischemia.Clinical utility of inappropriate positron emission tomography myocardial perfusion imaging: test results and cardiovascular events.Long-term prognostic value of stress myocardial perfusion imaging and coronary computed tomography angiography: A meta-analysis.Measurement of MBF by PET is ready for prime time as an integral part of clinical reports in diagnosis and risk assessment of patients with known or suspected CAD-PRO.Added prognostic value of ischaemic threshold in radionuclide myocardial perfusion imaging: a common-sense integration of exercise tolerance and ischaemia severity.The value and appropriateness of positron emission tomography: an evolving tale.The relationship of left ventricular mechanical dyssynchrony and cardiac sympathetic denervation to potential sudden cardiac death events in systolic heart failure.Warranty period of normal stress myocardial perfusion imaging in diabetic patients: a propensity score analysis.
P2860
Q26740081-0EDAA19B-980C-406B-86D9-D3E76D687812Q26827495-2A73D5F5-4021-4B62-8A1C-865AA717EAB1Q31011264-F95A503B-2D5B-4052-BE93-5054DDF20C5FQ35771737-68D46125-8E4E-43A4-96B9-7192E404DC40Q35956486-DD1FD90C-4587-474F-81A0-E57C342CE021Q36784060-371775D2-B728-4A6A-BC94-30A4D97F9657Q37071114-724750ED-CCC1-4EF9-87AB-FEF9E74FFEE1Q37656578-28CF2D62-6786-4F5A-92F6-142BE77B4009Q37689344-B11AFBAA-AC09-4C29-A3D5-AC833B7327E1Q38400209-3175AB30-8290-4118-8FE0-0545C06537BDQ38446630-CF2FF819-1DF0-40E7-9A21-F7FAE87C6F5AQ38449314-E9BDB5A0-B79C-4FBA-85E9-A0128D8DE136Q38541049-AF060E9E-8B0E-4132-811D-A9EE484BFBCFQ38739779-EA7592D2-3377-4618-B7E5-CDC9A47333E4Q38741610-24ECF189-B3BF-450F-8CE1-41810B0D6F0BQ38759839-23EFEB5E-8C1F-467D-92E5-7E03D13C07AFQ38808550-7E1A6453-59AB-4C87-B4BA-FDE1AD4C5E5CQ38958531-F64BACD1-1661-400B-94D7-DE8DE5020DD0Q39138116-EE48C55B-2D20-40C3-8CA0-B547F9AF77CAQ39225868-03E7FEE8-05CA-4275-9041-01B068BF1D32Q40113494-C8525AC7-57F4-4538-BCDB-C08B992F9109Q40896705-82C3B9AB-F92B-418D-8407-2E6F1A18E798Q42200095-47CF09E7-1346-4398-8716-55973C189651Q42219820-5682F463-B2FE-47FD-AB79-8A36743A1537Q42265941-E0B41822-50FB-41C7-864C-AD4BD0E6201FQ42370573-894A92FA-EA38-48B5-87FC-2CE04E86E37CQ43881395-36B3E578-C2D7-475B-939B-7D4ECCA9A790Q43899878-6D17C253-2CC7-480F-A006-699937258D8AQ45163651-E8E1C4CA-0DFC-4711-8C22-42CD45598D43Q45206767-158A8450-3F0D-45D4-B68F-0AEDA02E09BFQ47118369-30BBA456-1AE3-4A9A-B6BC-AD9F5F7CAADFQ48071634-152DA158-9493-4E8F-AA6E-8258D223E355Q48087008-19EEFDBA-63E3-42EE-B225-5EA3CFC03A21Q48241565-0B3997F7-50D9-4F04-938D-5D10A33D771AQ50235376-A761C00E-19D7-4283-9999-00CFCA08D8FEQ50497994-5062D43A-DF16-4560-B207-A69AB3F6D0F3Q50999403-46F69413-6931-4200-9E1D-DB8765036E51Q53054950-CDB26016-D0B4-4276-8F9A-7968320EBE97Q53090257-8CAFF488-6740-4693-BCE7-224E3F356506Q53093385-1EBA752B-75A3-4FE1-A381-0EBD9635BAA0
P2860
Prognosis in the era of comparative effectiveness research: where is nuclear cardiology now and where should it be?
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Prognosis in the era of compar ...... gy now and where should it be?
@en
type
label
Prognosis in the era of compar ...... gy now and where should it be?
@en
prefLabel
Prognosis in the era of compar ...... gy now and where should it be?
@en
P2093
P2860
P1476
Prognosis in the era of compar ...... gy now and where should it be?
@en
P2093
Ami Iskandrian
Daniel S Berman
Leslee J Shaw
Rory Hachamovitch
P2860
P2888
P304
P356
10.1007/S12350-012-9593-Y
P50
P577
2012-10-01T00:00:00Z